Abstract

IntroductionThe success of revascularisation therapies for coronary artery disease (CAD) must be measured by both an improvement in hard clinical endpoints—mortality, repeat revascularisation procedures and myocardial infarction, the traditional focus...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call